This section of the Zynex Medical InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Zynex Medical assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQZYXI
Beta0.77
Shares Outstanding40.1M
Average Volume (10 days)284.3K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$0.25
Sales (TTM)$2.24
Book Value (MRQ)$1.58
Cash Flow (TTM)($0.06)
Cash (MRQ)$0.92

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy4
 
Buy0
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Daniel J. Moorhead
Chief Financial Officer
(1,322)
Dispose
Jan 10, 2022
Daniel J. Moorhead
Chief Financial Officer
(463)
Dispose
Dec 13, 2021
Daniel J. Moorhead
Chief Financial Officer
(175)
Dispose
Nov 25, 2021
Anna Lucsok
Chief Operating Officer
1,197
Acquire
Nov 5, 2021
Daniel J. Moorhead
Chief Financial Officer
2,992
Acquire
Nov 5, 2021

Recent SEC Filings

Company Events
Jan 18, 2022
Insider Buy/Sell
Jan 10, 2022
Company Events
Dec 30, 2021
Company Events
Dec 23, 2021
Insider Buy/Sell
Dec 13, 2021